Publicis Health to Acquire p-value Group
New York, NY – July 29, 2025 – Publicis Health, the world’s most connected and data-powered health communications network, today announced its intent to acquire p-value Group, a premier full-service medical communications group serving top-tier life sciences clients. Founded in 2004 and headquartered in Cedar Knolls, New Jersey, p-value Group is widely recognized for its scientific rigor, deep therapeutic expertise, and a team of advanced-degree professionals. The agency is a trusted partner across the full product lifecycle, from early-stage development to commercialization.
This acquisition will uniquely position Publicis Health as the network to fuel the next generation of medical communications, which is the strategic bridge between scientific truth and commercial impact. As the life sciences industry faces rapid innovation, regulatory advancements, and increased competition, Publicis Health and p-value Group will accelerate the ability to connect data, technology, creative, therapeutic expertise and scientific integrity to shape strategy, inform decision-making, and drive outcomes-focused health results.
p-value Group will continue to be led by Founder and CEO Linda Corvari. The agency will sit within Publicis Health, strengthening the network's existing global expertise through Langland Medical and Razorfish Health, while underscoring the commitment to advancing how science is communicated across the product lifecycle.
“p-value Group has built a reputation for unmatched scientific rigor and client partnership,” said Matt McNally, Global CEO of Publicis Health. “By joining forces, we’re amplifying the value we deliver to clients by bringing greater precision, speed, and strategic alignment across medical communications. This is about scaling what works, removing barriers, and delivering smarter solutions that drive measurable impact for our clients.”
“This is more than an acquisition, it’s a strategic alignment of vision and velocity,” said Linda Corvari, PharmD, Founder and CEO of p-value Group. “Publicis Health brings the scale, innovation, and purpose to take our work even further. Together, we’re redefining what’s possible in medical communications.”
The transaction is subject to customary closing conditions, including regulatory approvals, and is expected to close by the end of August 2025.
About Publicis Health
At Publicis Health, we believe keeping the world healthy is our most extraordinary social endeavor. Because one person’s wellbeing is the responsibility of the many. As part of Publicis Groupe and built on the world’s foremost intelligence platform, we create sharper, more memorable, and valuable brands for better outcomes. Powered by more than 8,000 healthcare communications, data, and medical specialists, our global agency collective is at the heart of international health communications. We Make Health Happen. For more information, visit us at www.publicishealth.com.
About p-value Group
The p-value Group (PVG) is a medical communications and speakers bureau organization founded in 2004. It includes p-value communications, Scient Healthcare Communications, and the p-value Speakers Bureau. PVG supports pharmaceutical, biotech, and medical device clients around the world, from emerging start-ups to established global leaders. Known for its deep scientific expertise and flawless execution, PVG offers a full range of services across strategy, content development, training, meetings, congresses, and speaker bureau management. Its approach emphasizes proactive partnership, consistent teams, and white-glove service, ensuring every engagement delivers meaningful impact in healthcare communications.
Contact Publicis Groupe
Amy Hadfield
Director of Global Communications
+ 33 1 44 43 70 75
Michelle McGowan
EVP, Corporate Communications
+1 312 315 5259